Cite

MLA Citation

    Avivit Brener et al.. “Long-term safety of α-1 antitrypsin therapy in children and adolescents with Type 1 diabetes.” Immunotherapy, vol. 10, 2018, pp. 1137–1148. http://access.bl.uk/ark:/81055/vdc_100160955606.0x00000c
  
Back to record